alpha1-adrenergic receptor subtypes in human peripheral blood lymphocytes.
暂无分享,去创建一个
S. Tayebati | F. Amenta | F. Veglio | P. Mulatero | E. Bronzetti | D. Schiavone | A. Ricci | S. Greco | A. Conterno | M. Schena | Francesco Amenta | Andrea Conterno | Marina Schena
[1] P. Sleight. The sympathetic nervous system in hypertension: differing effects of drug treatment. , 1998, European heart journal.
[2] R. Jacobs,et al. Expression and in-vivo modulation of α- and β-adrenoceptors on human natural killer (CD16+) cells , 1997, Journal of Neuroimmunology.
[3] R. Schmieder,et al. Overview of α1-Adrenoceptor Antagonism and Recent Advances in Hypertensive Therapy , 1996 .
[4] C. Melchiorre,et al. Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist. , 1996, Journal of medicinal chemistry.
[5] R. Graham,et al. alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. , 1996, Circulation research.
[6] R. Villalobos-Molina,et al. α1-Adrenoceptors mediating contraction in arteries of normotensive and spontaneously hypertensive rats are of the α1D or α1A subtypes , 1996 .
[7] J. Hieble,et al. α‐ and β‐Adrenoceptors: From the Gene to the Clinic. Part 2. Structure‐Activity Relationships and Therapeutic Applications , 1996 .
[8] J. Hieble,et al. Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. , 1995, Journal of medicinal chemistry.
[9] M. S. Smith,et al. Identification of the mRNA for the novel alpha 1D-adrenoceptor and two other alpha 1-adrenoceptors in vascular smooth muscle. , 1994, Molecular pharmacology.
[10] P. Molinoff,et al. International Union of Pharmacology nomenclature of adrenoceptors. , 1994, Pharmacological reviews.
[11] B. Allolio,et al. Reduced lymphocyte β2‐adrenoceptor density and impaired diastolic left ventricular function in patients with glucocorticoid deficiency , 1994, Clinical endocrinology.
[12] C. Mathias,et al. Expression of beta-adrenoceptors on circulating mononuclear cells in hypertensives and normotensives before and after reduction of central sympathetic outflow by clonidine. , 1994, Blood pressure.
[13] G. Maestroni,et al. Noradrenergic modulation of lymphohematopoiesis. , 1994, International journal of immunopharmacology.
[14] M. Michel,et al. Radioligand binding studies of α1‐adrenoceptor subtypes in rat heart , 1994 .
[15] E. Borda,et al. Active alpha2 and beta adrenoceptors in lymphocytes from patients with chronic lymphocytic leukemia , 1991, International journal of cancer.
[16] M. Caron,et al. Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. , 1991, The Journal of biological chemistry.
[17] Debra,et al. Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. , 1990, The Journal of biological chemistry.
[18] M. Caron,et al. Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Daul,et al. Alpha- and beta-adrenoceptors in circulating blood cells of essential hypertensive patients: increased receptor density and responsiveness. , 1985, Clinical and experimental hypertension. Part A, Theory and practice.
[20] T. Casale,et al. Demonstration that circulating human blood cells have no detectable alpha 1-adrenergic receptors by radioligand binding analysis. , 1984, The Journal of allergy and clinical immunology.
[21] S. Titinchi,et al. Alpha 2-adrenoceptors in human lymphocytes: direct characterisation by [3H]yohimbine binding. , 1984, Biochemical and biophysical research communications.
[22] P. Molenaar,et al. Analysis of dose-response curves and calculation of agonist dissociation constants using a weighted nonlinear curve fitting program. , 1983, Journal of pharmacological methods.
[23] G. Delespesse,et al. Distribution of beta-adrenergic receptors on human lymphocyte subpopulations. , 1979, Clinical and experimental immunology.
[24] R. Schmieder,et al. Overview of alpha 1-adrenoceptor antagonism and recent advances in hypertensive therapy. , 1996, American journal of hypertension.
[25] M. Michel,et al. Radioligand binding studies of alpha 1-adrenoceptor subtypes in rat heart. , 1994, British journal of pharmacology.
[26] R. Lefkowitz,et al. Beta adrenergic receptors in lymphocyte subpopulations. , 1980, The Journal of allergy and clinical immunology.